Clinical Activity of SAAAB and HAABS Dietary Supplement on Hepatitis C and B Markers

Hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection is not uncommon as a result of similar routes of infection. Patients who are coinfected represent a unique group with diverse serologic profiles. Combined chronic hepatitis B and C leads to more severe liver disease and an increased risk of hepatocellular carcinoma. Furthermore, coinfected patients represent a treatment challenge but the liver can be toned by some herbal extracts to an extent of making hepatitis C becomes infinitesimal and render hepatitis B markers anergic. The herbal extracts are basically poly herbal preparation with Vernonia amygdalina as it active ingredient which is believed to strengthen the immune system through many cytokines and chemokines regulations. With the abundant presence of tannins, phlobatannins, flavonoids, steroids, terpenoids, saponins and cardiac glycosides, which are the most important bioactive constituents of medicinal plants, the poly herbal preparation is able to reverse hepatitis B envelop antigen (HBeAg) reactive to HBeAg non reactive and makes the surface antigen of the hepatitis B virus anergic within a span of three (3) weeks. The natural history and treatment of patients with HBV and HCV coinfection is reviewed.